Stay updated on Pembrolizumab for Metastatic Anal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3, indicating a minor site update without changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-04T13:26:00.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page now displays an updated revision identifier (v3.6.2), replacing the previous v3.6.0, indicating a minor platform version update.
    Difference
    0.1%
    Check dated 2026-06-27T08:09:34.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The study page now shows recruitment status as 'No longer looking for participants', and adds help sections 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The 'Intervention/Treatment' heading formatting has changed and the site revision tag updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-13T00:24:40.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    An administrative revision update was applied, replacing v3.5.4 with v3.5.5 on the page. This change does not modify any study content, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-06-05T21:53:26.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The revision label on the page has been updated from v3.5.3 to v3.5.4, indicating a backend/site update rather than a change to the study data.
    Difference
    0.1%
    Check dated 2026-05-15T15:12:31.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page revision label was updated from **v3.5.2** to **v3.5.3**, indicating a website/platform release rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-04-24T06:22:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Metastatic Anal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic Anal Cancer Clinical Trial page.